dactinomycin has been researched along with Carcinoma, Medullary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, JL; Patel, YC | 1 |
| Baylin, SB; Carson-Walter, EB; Nelkin, BD; Ponder, BA; Smith, DP | 1 |
2 other study(ies) available for dactinomycin and Carcinoma, Medullary
| Article | Year |
|---|---|
Glucocorticoids inhibit somatostatin gene expression through accelerated degradation of somatostatin messenger ribonucleic acid in human thyroid medullary carcinoma (TT) cells.
Topics: Carcinoma, Medullary; Cycloheximide; Dactinomycin; Dexamethasone; Dose-Response Relationship, Drug; Gene Expression; Humans; Kinetics; RNA, Messenger; Somatostatin; Thyroid Neoplasms; Tumor Cells, Cultured | 1995 |
Post-transcriptional silencing of RET occurs, but is not required, during raf-1 mediated differentiation of medullary thyroid carcinoma cells.
Topics: Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma, Medullary; Cell Differentiation; Cell Division; Cell Line; Cell Nucleus; Dactinomycin; Drosophila Proteins; Estradiol; Ethanol; Gene Expression Regulation, Neoplastic; Humans; Kinetics; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mitogen-Activated Protein Kinase Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms; Tumor Cells, Cultured | 1998 |